facebook twitter google print email
Media Contact:Lee-Ann Donegan | | 215-349-5660October 20, 2014

Penn Researchers Untangle the Biological Effects of Blue Light

Blue light can both set the mood and set in motion important biological responses.

facebook twitter google print email
Media Contact:Karen Kreeger | | 215-349-5658October 20, 2014

See-Through, One-Atom-Thick, Carbon Electrodes are a Powerful Tool for Studying Epilepsy, Other Brain Disorders, Penn Study Finds

Researchers from the Perelman School of Medicine and 

facebook twitter google print email
Media Contact:Katherine Unger Baillie | | 215-898-9194December 1, 2014

Penn Dental Medicine Welcomes Its First Thouron Scholar

This year, the Thouron Scholars, a community of 700-plus whose disciplines range from geology to English literature, welcomed their very first dentist to the ranks.

By Madeleine Stone  @themadstone

facebook twitter google print email
Media Contact:Katie Delach | | 215-349-5964October 16, 2014

Penn Medicine Researchers Zero in on Psoriasis-Hypertension Link

Patients with more severe psoriasis are also more likely to have uncontrolled hypertension, according to new research by a team at the Perelman School of Medicine at the University of Pennsylvania

facebook twitter google print email
Media Contact:Katherine Unger Baillie | | 215-898-9194November 11, 2014

Collaborative Penn-Dresden Study Blocks Multiple Sclerosis Relapses in Mice

In a new study, researchers from the University of Pennsylvania and co-investigators have identified a key protein that is able to reduce the severity of a disease equivalent to multiple sclerosis in mice.

In multiple sclerosis, the immune system goes rogue, improperly attacking the body’s own central nervous system. Mobility problems and cognitive impairments may arise as the nerve cells become damaged.

facebook twitter google print email
Media Contact:Anna Duerr | | 215-349-8369November 5, 2014

Readmission Rates Above Average for Survivors of Septic Shock, Penn Study Finds

Penn Medicine researchers have now shown that while most patients now survive a hospital stay for septic shock, 23 percent will return to the hospital within 30 days, many with another life-threatening condition -- a rate substantially higher than the normal readmission rate at a large academic medical center.

A diagnosis of septic shock was once a near death sentence. At best, survivors suffered a substantially reduced quality of life.

facebook twitter google print email
Media Contact:Katie Delach | | 215-349-5964November 6, 2014

Penn Study: Olaparib Shows Promise As Treatment Option for Patients with BRCA-Related Cancers

A Penn Medicine study Finds Olaparib shows success in tumor response rate for patients with BRCA-related cancers. The study's results provide promising treatment option and improved survival rates for patients with ovarian, breast, pancreatic and prostate cancers

Olaparib, an experimental twice-daily oral cancer drug, produces an overall tumor response rate of 26 percent in several advanced cancers associated with BRCA1 and BRCA2 mutations, according to new research co-led by the Abramson Cancer Center of the University of Pennsylvania.

facebook twitter google print email
Media Contact:Karen Kreeger | | 215-349-5658November 10, 2014

Classification of Gene Mutations in a Children's Cancer May Point to Improved Treatments

Penn Medicine and CHOP Experts Define Riskier Mutations in Neuroblastoma, Setting Stage for Clinical Trial

Oncology researchers studying gene mutations in the childhood cancer neuroblastoma are refining their diagnostic tools to predict which patients are more likely to respond to drugs called ALK inhibitors that target such mutations. Removing some of the guesswork in diagnosis and treatment, the researchers say, may lead to more successful outcomes for children with this often-deadly cancer.

facebook twitter google print email
Media Contact:Evan Lerner | | 215-573-6604November 10, 2014

Penn Center for Innovation Celebrates Launch


Amy Gutmann
President, University of Pennsylvania

Michael A. Nutter
Mayor, City of Philadelphia

Dawn Bonnell
Vice Provost for Research

John Swartley
Director, Penn Center for Innovation
Assistant Vice Provost for Research


 Penn Center for Innovation Launch Celebration


Nov. 17, 2014
4 p.m – 6 p.m.


Prince Theater
The Annenberg Center for the Performing Arts
3680 Walnut St.


The Penn Center for Innovation, a new initiative that will provide the infrastructure, leadership and resources needed to transfer promising Penn inventions, know-how and related assets into the marketplace for the public good, will be formally launched at an event on Monday, November 17.

Gutmann, Nutter, Bonnell and Swartley will discuss how PCI will accelerate the translation of Penn discoveries and ideas into commercial products, businesses, and services, as well as the role the University plays in the local, national and global entrepreneurial ecosystem. 

Top Penn researchers and members of the business and venture capital community will have the opportunity to meet at a reception to follow. 

Attendance is free and open to the public, but email registration is mandatory.    

Chomping on Ice Might Provide a Mental Boost for Those With Disorder, Study Finds

November 8, 2014

Melissa Hunt of the School of Arts & Sciences is highlighted for studying why people with iron-deficiency anemia of

Article Source: Washington Post